A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
This is an open‐label, randomized, 3x3 partial replicated crossover study to evaluate the pharmacokinetics and safety/tolerability. Within each period, randomized subjects will be 2 dosing regimens with a fixed dose combination of Fimasartan/Linagliptin and co‐administration of Fimasartan and Linagliptin.
Epistemonikos ID: f3eaf586c59a160cf452bd11b483f8c499a3a7e3
First added on: Dec 20, 2022